[Gly1,Ser3,22,Gln4,34,Thr6,Ala19,Tyr21,Ala23,31, Aib32]-Pancreat

(image for) [Gly1,Ser3,22,Gln4,34,Thr6,Ala19,Tyr21,Ala23,31, Aib32]-Pancreat
Product Name
[Gly1,Ser3,22,Gln4,34,Thr6,Ala19,Tyr21,Ala23,31, Aib32]-Pancreat
Product Quantity
5mg
Catalog Number
LT0610
Molecular Weight
4207.73
Formula
C183H281N57O54S2
Sequence
Gly-Pro-Ser-Gln-Pro-Thr-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Ala-Aib-Arg-Gln-Arg-Tyr-NH2
Scientific Background

[Gly1,Ser3,22,Gln4,34,Thr6,Ala19,Tyr21,Ala23,31, Aib32]-Pancreat is a 35-residue synthetic peptide with the sequence Gly-Pro-Ser-Gln-Pro-Thr-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Ala-Arg-Gln-Arg-Tyr. C-terminal amidation removes the terminal carboxylate charge. The sequence contains 0 Lys and 5 Arg residues, contributing cationic character; contains 5 aromatic residues that can contribute to hydrophobic or aromatic interactions. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence.

Research Applications
  • LC-MS/HPLC analytical method development
  • sequence-specific assay controls
Experimental Notes

Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions.

  • 5 Units in Stock
Ask a Question

$881.28

Add to Cart: